keyword
https://read.qxmd.com/read/38618931/experimental-and-new-investigational-drugs-for-the-treatment-of-uterine-fibroids
#1
REVIEW
Giulio Evangelisti, Simone Ferrero, Umberto Perrone, Claudio Gustavino, Eugenio Volpi, Alberto Izzotti, Fabio Barra
INTRODUCTION: Uterine fibroids, the most prevalent benign tumors among reproductive-age women, pose treatment challenges that range from surgical interventions to medical therapies for symptom control. Progestins and estroprogestins effectively manage uterine bleeding by suppressing dysfunctional endometrium over fibroids. While GnRH agonists represent a crucial milestone in symptom treatment, their prolonged use results in menopausal-like symptoms and irreversible bone mineral density loss...
April 15, 2024: Expert Opinion on Investigational Drugs
https://read.qxmd.com/read/38458359/ulipristal-upa-effects-on-rat-ovaries-unraveling-follicle-dynamics-ovulation-inhibition-and-safety-implications-for-prolonged-use
#2
JOURNAL ARTICLE
Mana Hirano, Osamu Wada-Hiraike, Motoko Fukui, Seiji Shibata, Mari Uehara, Aiko Nagumo, Yoko Urata, Kenbun Sone, Miyuki Harada, Kaori Koga, Yutaka Osuga
Ulipristal (UPA), a selective progesterone receptor modulator, has both agonistic and antagonistic effects on progesterone receptors. UPA suppresses ovulation by inhibiting the luteinizing hormone (LH) surge from the pituitary gland; however, the direct effect of UPA on ovarian tissue remains poorly studied. In the present study, we examined the effects of UPA on the ovaries of rats. Rats were treated for 28 days with UPA, and the effects of UPA on ovarian tissue were examined histologically and the expression of antioxidant genes and cell death markers were also investigated...
March 6, 2024: Reproductive Toxicology
https://read.qxmd.com/read/38295626/white-matter-volume-and-treatment-with-selective-progesterone-receptor-modulator-in-patients-with-premenstrual-dysphoric-disorder
#3
JOURNAL ARTICLE
Elisavet Kaltsouni, Johan Wikström, Rupert Lanzenberger, Inger Sundström-Poromaa, Erika Comasco
Premenstrual dysphoric disorder (PMDD) is a mood disorder for which selective progesterone receptor modulator (SPRM) treatment has been demonstrated to be beneficial. The neural signatures of this treatment have been so far identified as greater fronto-cingulate reactivity during aggressive response to provocation, but no changes in terms of gray matter structure. White matter has recently been found to differ between patients with PMDD and healthy controls. The present study thus sought to investigate the relationship between white matter volume and SPRM treatment in patients with PMDD...
January 22, 2024: Psychoneuroendocrinology
https://read.qxmd.com/read/38288390/knowledge-of-oral-emergency-contraception-among-pharmacy-students
#4
JOURNAL ARTICLE
Bria Nikole Blake, Samantha Bookbinder, Gweneth Lazenby, Amari Marshall, Elizabeth Weed, Michelle Meglin
BACKGROUND: Access to emergency contraception is an important consideration in preventing unintended pregnancies. Inconsistent information about emergency contraceptive given to patients at retail pharmacies may limit access. OBJECTIVE: In this study, we aimed to assess pharmacy students' knowledge of oral emergency contraception. METHODS: Students in a Doctor of Pharmacy program completed a confidential survey about their knowledge of and training on oral emergency contraception...
2024: Women's health reports
https://read.qxmd.com/read/38232940/pharmacodynamic-evaluation-of-the-etonogestrel-contraceptive-implant-initiated-midcycle-with-and-without-ulipristal-acetate-an-exploratory-study
#5
JOURNAL ARTICLE
Lori M Gawron, Jennifer E Kaiser, Alexandra Gero, Jessica N Sanders, Erica B Johnstone, David K Turok
OBJECTIVE: To estimate the incidence of ovulation suppression within five days of etonogestrel 68 mg implant insertion in the presence of a dominant follicle with and without same-day ulipristal acetate. STUDY DESIGN: This single site non-masked, exploratory randomized trial recruited people age 18-35 years with regular menstrual cycles, no pregnancy risk, and confirmed ovulatory function. We initiated transvaginal ultrasound examinations on menstrual day 7-9 and randomized participants 1:1 to etonogestrel implant alone or with concomitant ulipristal acetate 30 mg oral when a dominant follicle reached ≥14mm in diameter...
January 15, 2024: Contraception
https://read.qxmd.com/read/38160962/emergency-contraception-in-a-historic-southern-city-mystery-caller-study-in-birmingham-alabama
#6
JOURNAL ARTICLE
Heami Yi, Carol A Stamm, Garth Wright, Wei-San Mondie, Leanne Rupp, Laura Borgelt
Alabama's Human Life Protection Act (the Act) signed in 2019 became law in 2022, making provision of abortion a felony offense. In 2020, our objective was to assess the accessibility of emergency contraception (EC) pills in Birmingham, Alabama prior to the Act's enactment given the probable increased need for EC access due to abortion criminalization. Pharmacy staff were asked about availability, price, location, and any identification (ID) requirements to obtain EC. Of 69 included pharmacies, 59% had levonorgestrel (LNG) EC and none had ulipristal acetate (UPA) EC available...
December 29, 2023: Contraception
https://read.qxmd.com/read/37987267/novel-approaches-to-possible-targeted-therapies-and-prophylaxis-of-uterine-fibroids
#7
REVIEW
Maria V Kuznetsova, Narine M Tonoyan, Elena V Trubnikova, Dmitry V Zelensky, Ksenia A Svirepova, Leila V Adamyan, Dmitry Y Trofimov, Gennady T Sukhikh
Uterine leiomyomas are the most common benign tumors in women of childbearing age. They may lead to problems of conception or complications during the gestational period. The methods of treatment include surgical (myomectomy and hysterectomy, embolization of arteries) and therapeutic treatment (ulipristal acetate, leuprolide acetate, cetrorelix, goserelin, mifepristone). Both approaches are efficient but incompatible with pregnancy planning. Therefore, there is a call for medical practice to develop therapeutical means of preventing leiomyoma onset in patients planning on becoming pregnant...
November 1, 2023: Diseases (Basel)
https://read.qxmd.com/read/37930357/-emergency-contraception
#8
JOURNAL ARTICLE
Lotti Lőczi, Márton Vezér, Marianna Török, Richárd Cseh, Attila Keszthelyi, Nándor Ács, Szabolcs Várbíró, Márton Keszthelyi
INTRODUCTION: Emergency contraception is an effective and safe solution for preventing unwanted pregnancies. Many methods of emergency contraception are used, which have different mechanisms of action and time frames. OBJECTIVE: Providing information to healthcare professionals and decision-makers based on the literature data about the target populations of emergency contraception, evidence-based modern methods, their effectiveness, and practical application for the purpose of reducing the incidence of unintended pregnancies...
November 5, 2023: Orvosi Hetilap
https://read.qxmd.com/read/37924789/ulipristal-acetate-a-selective-progesterone-receptor-modulator-induces-cell-death-via-inhibition-of-stat3-ccl2-signaling-pathway-in-uterine-sarcoma
#9
JOURNAL ARTICLE
Jae Ryoung Hwang, Young-Jae Cho, Ji-Yoon Ryu, Ju-Yeon Choi, Jung-Joo Choi, Jason K Sa, Hyun-Soo Kim, Jeong-Won Lee
Ulipristal acetate (UPA) is a selective progesterone receptor modulator and is used for the treatment of uterine leiomyoma (a benign tumor). Uterine sarcoma which is highly malignant cancer with a poor prognosis is clinically resembled with uterine leiomyoma. There has been no experimental research on the effect of UPA on uterine sarcoma. In this study, we examined the efficacy of UPA in uterine sarcoma with in vitro and in vivo animal models. Cytotoxicity of UPA was determined in uterine sarcoma cell lines (MES-SA, SK-UT-1, and SK-LMS-1)...
November 2, 2023: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/37922775/emergency-contraception-a-review
#10
REVIEW
Patryk Rudzinski, Inga Lopuszynska, Dorota Pazik, Dominik Adamowicz, Anna Jargielo, Aleksandra Cieslik, Karolina Kosieradzka, Justyna Stanczyk, Astrik Meliksetian, Alicja Wosinska
Emergency contraception (EC), or postcoital contraception, is a therapy aimed at preventing unintended pregnancy after an act of unprotected or under-protected sexual intercourse. Options include both emergency contraceptive pills (most commonly containing levonorgestrel or ulipristal acetate) and insertion of an intrauterine device. The aim of this paper is to summarize current evidence surrounding the use of emergency contraceptives and to present an evidence-based approach to EC provision. Emergency contraception is a safe and effective option in preventing unwanted pregnancy, irrespective of age, weight, or breastfeeding status...
December 2023: European Journal of Obstetrics, Gynecology, and Reproductive Biology
https://read.qxmd.com/read/37834773/the-present-and-the-future-of-medical-therapies-for-adenomyosis-a-narrative-review
#11
REVIEW
Gaby Moawad, Youssef Youssef, Arrigo Fruscalzo, Hani Faysal, Mira Kheil, Paul Pirtea, Benedetta Guani, Jean Marc Ayoubi, Anis Feki
Uterine Adenomyosis is a benign condition characterized by the presence of endometrium-like epithelial and stromal tissue in the myometrium. Several medical treatments have been proposed, but still, no guidelines directing the management of adenomyosis are available. While a hysterectomy is typically regarded as the definitive treatment for adenomyosis, the scarcity of high-quality data leaves patients desiring fertility with limited conservative options. Based on the available data, the levonorgestrel-IUD appears to offer the most favorable outcomes...
September 22, 2023: Journal of Clinical Medicine
https://read.qxmd.com/read/37790088/over-the-counter-emergency-contraception-in-italy-ethical-reflections-and-medico-legal-issues
#12
JOURNAL ARTICLE
Roberto Scendoni, Mariano Cingolani, Fabio Cembriani, Piergiorgio Fedeli, Vittoradolfo Tambone, Corrado Terranova, Francesco De Micco
Although more than ten years have passed since the marketing of Ulipristal acetate in Europe, emergency contraception remains a complex issue with many scientific, legal, ethical and social implications. The topic is an example of the differences that can exist between scientific evidence, the certainties on which law is based, and social implications. This paper shows the incompleteness of the scientific reconstruction on the effects of emergency hormonal contraceptives and the dangerousness of the decision to alienate the supply of over-the-counter drugs from the general rules of health care...
2023: Frontiers in global women's health
https://read.qxmd.com/read/37766684/next-step-in-the-development-of-mesoprogestins-the-preclinical-profile-of-ec313
#13
JOURNAL ARTICLE
K Błaszczak-Świątkiewicz, A Krupa, E Mnich, W Elger, M Oettel, H Nair, M Wierzbicki, P Sieroszewski, Z Shaked
INTRODUCTION: The pharmacological target for progesterone, different progestins, and Selective Progesterone Receptor Modulators (SPRMs) is the nuclear progesterone receptor (PR). EC313 is a new member of a subgroup of SPRMs, mesoprogestins, which combine especially PR- agonistic and PR-antagonistic activities in one molecule. METHODS: The suitable in vivo -model for the differentiation of SPRMs from the subgroup of mesoprogestins is the estrogen-primed juvenile rabbit endometrium assay (McPhail Assay)...
2023: Frontiers in Endocrinology
https://read.qxmd.com/read/37700209/effects-of-ulipristal-acetate-on-reactive-oxygen-species-and-proinflammatory-cytokine-release-by-epithelial-and-stromal-cells-from-human-endometrium-and-endometriosis
#14
JOURNAL ARTICLE
Fernando M Reis, Sandrine Chouzenoux, Mathilde Bourdon, Mohamed Jeljeli, Charles Chapron, Frédéric Batteux
Endometriosis is a condition characterized by increased oxidative stress and chronic inflammation, which can be treated with progestins and other progesterone receptor ligands. However, some patients are refractory to this treatment and the reason is uncertain. Here we investigated the effects of the selective progesterone receptor modulator ulipristal acetate (UPA) on proliferation, reactive oxygen species (ROS), and proinflammatory cytokine production by endometriotic cells and endometrial cells from women with histologically proven endometriosis (n = 22) and endometriosis-free controls (n = 6)...
September 12, 2023: Reproductive Sciences
https://read.qxmd.com/read/37668348/role-of-med12-mutation-in-the-pathogenesis-of-uterine-fibroids
#15
REVIEW
Hiroshi Ishikawa, Tatsuya Kobayashi, Meika Kaneko, Yoshiko Saito, Makio Shozu, Kaori Koga
Uterine fibroids (UFs) are benign tumors arising from the uterus, characterized by accumulation of abundant extracellular matrix (ECM) and sex steroids dependent growth. Women with symptomatic UFs have reduced quality of life and decreased labor productivity. Among the driver gene mutations identified in UFs, mutations in MED12, a component of the cyclin-dependent kinase (CDK) Mediator module, are the most common and observed in 50-80% of UFs. They are gain-of-function mutations and are more frequently observed in Black women and commonly observed even in small UFs...
September 1, 2023: Journal of Molecular Endocrinology
https://read.qxmd.com/read/37590937/forensic-nurses-understanding-of-emergency-contraception-mechanisms-implications-for-access-to-emergency-contraception
#16
JOURNAL ARTICLE
Nancy R Downing, Elaine Avshman, Julie L Valentine, Luke M Johnson, Hector Chapa
BACKGROUND: An estimated 25,000 pregnancies result from sexual assault in the United States annually. Numerous professional healthcare organizations endorse offering emergency contraception (EC) as an integrated aspect of post-sexual-assault care. Lack of knowledge surrounding EC's mechanism of action, including misinterpreting ECs as abortifacients, might restrict patient access to this important healthcare option. PURPOSE: We evaluated sexual assault nurse examiners' understanding of the mechanism of action of oral ECs levonorgestrel (LNG) and ulipristal acetate (UPA)...
July 2023: Journal of Forensic Nursing
https://read.qxmd.com/read/37585996/decreased-growth-differentiation-factor-9-bone-morphogenetic-protein-15-and-forkhead-box-o3a-expressions-in-the-ovary-via-ulipristal-acetate
#17
JOURNAL ARTICLE
Damla Gül Fındık, Gülnur Take Kaplanoğlu, Gökçe Nur Arık, Nagwa Bugumaa Abubaker Alemari
OBJECTIVE: Folliculogenesis is a complex process involving various ovarian paracrine factors. During folliculogenesis, vitamin D3 and progesterone are significant for the proper development of follicles. This study aimed to investigate the effects of vitamin D3 and selective progesterone receptor modulator ulipristal acetate on ovarian paracrine factors. METHODS: In the study, 18 female Wistar-albino rats were randomly divided into three groups: control group (saline administration, n=6), vitamin D3 group (300 ng/day vitamin D3 oral administration, n=6), and UPA group (3 mg/kg/day ulipristal acetate oral administration, n=6)...
2023: Revista da Associação Médica Brasileira
https://read.qxmd.com/read/37563061/-a-lot-of-my-friends-don-t-know-how-it-works-student-activists-describe-gaps-in-college-students-emergency-contraception-knowledge
#18
JOURNAL ARTICLE
Brandon Wagner, Nicola Brogan, Kelly Cleland
INTRODUCTION: Despite the high potential need for emergency contraception (EC) among college students, lack of accurate knowledge may decrease the likelihood of its use in this population. We examined knowledge about EC methods, potential outcomes of use, and access among college students in the United States. METHODS: We recruited college students from a listserv devoted to EC campus activism for an online survey about EC knowledge (N = 150) and conducted 24 follow-up in-depth interviews...
August 8, 2023: Women's Health Issues: Official Publication of the Jacobs Institute of Women's Health
https://read.qxmd.com/read/37560806/oral-gonadotrophin-releasing-hormone-gnrh-antagonists-the-continuing-search-for-the-ideal-nonsurgical-therapy-of-uterine-fibroids-with-a-cautionary-tale
#19
JOURNAL ARTICLE
Ogagaoghene Sim-Ifere, Mehrnoosh Aref-Adib, Funlayo Odejinmi
PURPOSE OF REVIEW: Uterine fibroids are very common with a prevalence of over 70%. They present a significant economic and psychological burden. A variety of nonsurgical treatments exist for its management encompassing hormonal and nonhormonal methods. Gonadotrophin-releasing hormone (GnRH) antagonists are a novel treatment for uterine fibroids. They cause a rapid reduction in endogenous GnRH, leading to a dose-dependent reduction in levels of oestradiol and progesterone, thus reduction in bleeding...
August 10, 2023: Current Opinion in Obstetrics & Gynecology
https://read.qxmd.com/read/37542704/gaba-ergic-modulators-new-therapeutic-approaches-to-premenstrual-dysphoric-disorder
#20
REVIEW
Christopher Sikes-Keilp, David R Rubinow
Premenstrual dysphoric disorder (PMDD) is characterized by the predictable onset of mood and physical symptoms secondary to gonadal steroid fluctuation during the luteal phase of the menstrual cycle. Although menstrual-related affective dysfunction is responsible for considerable functional impairment and reduction in quality of life worldwide, currently approved treatments for PMDD are suboptimal in their effectiveness. Research over the past two decades has suggested that the interaction between allopregnanolone, a neurosteroid derivative of progesterone, and the gamma-aminobutyric acid (GABA) system represents an important relationship underlying symptom genesis in reproductive-related mood disorders, including PMDD...
August 2023: CNS Drugs
keyword
keyword
166796
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.